As many in the hemp industry have long expected, earlier this week the FDA approved Epidiolex — which contains cannabidiol (CBD) isolate derived from marijuana — as a prescription drug for treatment of epileptic conditions, Dravet or Lennox-Gastaut...
The Press Release https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm611046.htm Here are some of the press reports The Guardian UK UK epilepsy drug to become first cannabis-based medicine in US Epidiolex set for autumn launch after US Food and Drug...
Report… Barring an unexpected decision from the FDA, GW Pharma, which will hear from the agency by Wednesday, will make history this week when it receives approval for Epidiolex, its oral CBD solution that treats the seizures caused by rare forms of epilepsy....
Earlier this month, on April 9, 2018, FDA published a notice requesting comments from the public on the scheduling of cannabis-related substances (“Cannabis Plant and Resin; Extracts and Tinctures of Cannabis; Delta-9-Tetrahydrocannabinol; Stereoisomers of...
Hemp Industry Daily reports A panel of government health advisers gave a unanimous recommendation Thursday to the U.S. Food and Drug Administration to approve Epidiolex, a CBD medicine for rare epilepsy conditions that don’t respond to other drugs. A final decision on...